Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Oncology Nursing›Cancer Fatigue Scale (CFS)
Process / pipelineThree-Dimensional Fatigue Assessment

Cancer Fatigue Scale (CFS)

Also known as: CFS, Okuyama Fatigue Scale

The Cancer Fatigue Scale is a 15-item disease-specific self-report instrument that comprehensively assesses three dimensions of cancer-related fatigue: physical, cognitive, and emotional. Developed by Takuo Okuyama and colleagues at the Japanese Foundation for Cancer Research and published in 2000, the CFS provides a brief yet multidimensional fatigue profile suitable for both clinical practice and research, with particular strength in non-English-speaking populations where it has been extensively validated.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Cancer Fatigue Scale
Brief Fatigue InventoryChalder Fatigue ScaleESASMFIPiper Fatigue Scale

When to use it

CFS is appropriate for any cancer type and stage. Use in clinical trials as a primary or secondary outcome, particularly in trials of supportive care (exercise, psychotherapy, pharmacotherapy) where understanding fatigue dimensionality is important. Employ in observational research examining fatigue prevalence, trajectories, and associations with clinical/psychosocial factors. In routine clinical oncology, integrate CFS into symptom-screening protocols to identify patients with clinically significant fatigue, particularly cognitive or emotional components that may drive intervention strategy. Particularly valuable in non-English-speaking and culturally diverse cancer populations, where CFS has strong validation evidence.

Strengths & limitations

Strengths
  • Concise three-dimensional model (15 items); captures physical, cognitive, and emotional fatigue efficiently without excessive burden. Fewer items than Piper (22) or MFI (20), but retains multidimensional rigor.
  • Extensively validated across cancer types (gastric, lung, breast, colorectal, etc.), treatment phases, and 20+ languages. Strong internal consistency (Cronbach α ≥0.80 for subscales) and test–retest reliability (ICC ≥0.75).
  • Responsive to change with exercise, supportive care, and psychological interventions; sensitive to treatment-related fatigue fluctuations.
  • Strong cross-cultural psychometric evidence; particularly well-validated in Asian and European populations alongside English-speaking cohorts.
Limitations
  • Subscale interpretation thresholds (5–10, 11–17, 18–25) are empirically derived but not universally validated. Cutoff specificity varies by cancer type and treatment phase; reference data are essential.
  • Mild ceiling effect in survivor populations with minimal fatigue; may not detect subtle improvements in already-low fatigue subgroups.
  • Emotional subscale items overlap conceptually with depression/anxiety symptoms; high emotional fatigue score does not diagnose mood disorder but warrants screening.
  • Limited mechanistic depth; does not address behavioral interference, symptom trajectories, or fatigue etiologies (treatment-related, disease-related, psychosocial). Use alongside other instruments if detailed mechanism mapping is required.

Frequently asked

How do I distinguish emotional fatigue on the CFS from depression?

Emotional fatigue on the CFS specifically measures mood dysregulation and existential burden related to cancer fatigue (e.g., 'I feel depressed because of fatigue'). It is not equivalent to major depression. If CFS emotional subscale is elevated, use concurrent PHQ-9 (depression) or GAD-7 (anxiety) screening to assess comorbid mental health disorders. High CFS emotional fatigue may warrant psychosocial support, mindfulness, or cognitive-behavioral therapy; concurrent depression may require antidepressants or specialist mental health referral.

What is a clinically meaningful change in CFS scores?

Published estimates suggest a total CFS change of ≥5–10 points represents clinically meaningful improvement, with context-specific variation. In severe baseline fatigue (CFS 60+), a 10-point reduction is meaningful; in moderate baseline (CFS 35–45), 5–7 points may suffice. Subscale changes of ≥3–5 points are considered meaningful per dimension. Use effect-size benchmarks (Cohen d, small ~0.2, medium ~0.5, large ~0.8) alongside raw score changes for comprehensive interpretation.

Can CFS be used in non-cancer fatigue conditions (e.g., ME/CFS, long COVID)?

The CFS was developed and extensively validated specifically in cancer populations. Using it in other chronic fatigue conditions (myalgic encephalomyelitis/chronic fatigue syndrome, post-viral fatigue, etc.) requires dedicated validation studies. The three-dimensional model may be conceptually relevant, but normative data, cutoffs, and responsiveness are cancer-specific. Consider disease-specific fatigue instruments (Chalder Fatigue Scale, Multidimensional Fatigue Inventory) for non-cancer conditions.

How does CFS compare to other multidimensional fatigue scales?

CFS (15 items, three subscales: physical/cognitive/emotional) is more concise than Piper Fatigue Scale (22 items, four subscales: behavioral/affective/sensory/cognitive) or MFI (20 items, five subscales: general, physical, reduced activity, reduced motivation, mental). CFS is practical for busy clinics and integrates well into routine screening. Piper and MFI offer greater detail for research requiring mechanistic fatigue phenotyping. Choose CFS for clinical screening and repeated assessment; use Piper or MFI when detailed fatigue architecture is essential.

Sources

  1. Okuyama, T., Akechi, T., Kugaya, A., et al. (2000). Development and validation of a cancer fatigue scale: a brief, three-dimensional, disease-specific instrument. J Pain Symptom Manage, 19(1), 5–14. DOI: 10.1016/s0885-3924(99)00138-4 ↗
  2. Okuyama, T., Akechi, T., Endo, C., et al. (2000). Validation of the Cancer Fatigue Scale (CFS) in gastric cancer patients. J Pain Symptom Manage, 19(4), 324–330. DOI: 10.1037/t49198-000 ↗

How to cite this page

ScholarGate. (2026, June 3). Cancer Fatigue Scale (CFS). ScholarGate. https://scholargate.app/en/oncology-nursing/cancer-fatigue-scale

Related methods

Brief Fatigue InventoryChalder Fatigue ScaleESASMFIPiper Fatigue Scale

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Brief Fatigue InventoryOncology Nursing↔ compare
  • Chalder Fatigue ScaleOncology Nursing↔ compare
  • ESASOncology Nursing↔ compare
  • MFIOncology Nursing↔ compare
  • Piper Fatigue ScaleOncology Nursing↔ compare
Compare side by side →

Referenced by

Brief Fatigue InventoryChalder Fatigue ScaleMFIPiper Fatigue Scale

Similar methods

Chalder Fatigue ScalePiper Fatigue ScaleMFIBrief Fatigue InventoryFACT-GEORTC QLQ-C30Cancer Worry ScaleEORTC QLQ-C15-PAL

Related reference concepts

Cancer Rehabilitation and Quality of LifeCancer Pain ManagementPsychosocial OncologyCancer Survivorship and Late EffectsSpecial Topics in Medical OncologyCancer

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Cancer Fatigue Scale (Cancer Fatigue Scale (CFS)). Retrieved 2026-07-21 from https://scholargate.app/en/oncology-nursing/cancer-fatigue-scale · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Takuo Okuyama
Subfamily
Three-Dimensional Fatigue Assessment
Year
2000
Type
Patient self-report three-dimensional fatigue scale
Related methods
Brief Fatigue InventoryChalder Fatigue ScaleESASMFIPiper Fatigue Scale
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account